Impact of AI on the Pharmaceutical Industry: Examining the Role of Precision Medicine in Drug Development and Market Trends

EasyChair Preprint 15224

Abstract

This article explores the transformative impact of Artificial Intelligence (AI) on the pharmaceutical industry, particularly through the lens of precision medicine. It begins by defining AI and precision medicine, highlighting their significance within the evolving pharmaceutical landscape. The article delves into how AI enhances precision medicine by analyzing genomic data and identifying patient subpopulations, ultimately streamlining drug discovery and clinical trials. It also discusses the implications of AI on market dynamics, including shifts in competition, pricing strategies, and regulatory frameworks. Additionally, the article addresses challenges such as data privacy and the integration of AI solutions into existing systems, emphasizing the need for collaboration among stakeholders. Finally, it offers a future outlook on the potential advancements in technology and their long-term implications for healthcare delivery. This comprehensive examination underscores the necessity for industry stakeholders to embrace AI and precision medicine to improve patient outcomes and maintain competitiveness in an increasingly complex market.

Keyphrases: Artificial Intelligence, Integration, enhances precision

@booklet{EasyChair:15224,
  author    = {George Christopher and A Kondam and Sh Jacobson},
  title     = {Impact of AI on the Pharmaceutical Industry: Examining the Role of Precision Medicine in Drug Development and Market Trends},
  howpublished = {EasyChair Preprint 15224},
  year      = {EasyChair, 2024}}